Mediclin AG Stock
Price
Target price
€3.98
€3.98
0.500%
0.02
0.500%
-
22:25 / Tradegate
WKN: 659510 / Name: MEDICLIN / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Mediclin AG Stock
The Mediclin AG stock is trending slightly upwards today, with an increase of €0.020 (0.500%) compared to yesterday's price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Mediclin AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Mediclin AG in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mediclin AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mediclin AG | 0.500% | -1.961% | 12.994% | 30.719% | 11.732% | 30.719% | -4.306% |
| Vita 34 AG | 2.360% | -0.262% | -3.299% | -9.716% | -37.541% | -32.923% | -75.179% |
| M1 Kliniken AG | -0.980% | -0.760% | -2.559% | 28.191% | -4.792% | 147.027% | 71.643% |
| Healthstream Inc. | 0.000% | -0.909% | 6.863% | -6.838% | 11.795% | -0.909% | -0.909% |
News
EQS-News: MEDICLIN AG: Annual General Meeting approves all proposed resolutions
EQS-News: MEDICLIN AG: Annual General Meeting approves all proposed resolutions
EQS-News: MEDICLIN increases group operating result in the first quarter
EQS-News: MEDICLIN increases group operating result in the first quarter
EQS-News: MEDICLIN lays a solid foundation for further growth with its 2025 financial results
EQS-News: MEDICLIN lays a solid foundation for further growth with its 2025 financial results